Advancing 21st Century Pain Management Conference (August 17, 2018)

  • CMPI | by: CMPI |
  • 07/24/2018 12:00 AM
by is licensed under
Advancing 21st Century Pain Management 
 
 
The Current State of Abuse Deterrent Technology Development and Adoption
 
Challenges and Opportunities
 
Co-sponsored by the Innovative Pain Medicines Alliance and the Abuse Deterrent Coalition
 
Featuring FDA Commissioner Scott Gottlieb, M.D. 
 
 
Join the Center for Medicine in the Public Interest on Friday, August 17 at the National Press Club to explore risks and opportunities related to policy for a discussion of abuse deterrent technologies and their place in the 21st Century Pain Management Arsenal. 
 
Our program will feature a slate of expert panels, as well as a keynote address from Food and Drug Administration (FDA) Commissioner Scott Gottlieb, M.D. 
 
This invitation is non-transferable. 
Room size is limited: Each organization may provide up to two attendees.
Kindly RSVP by August 3.
 
 
When: Friday, August 17
8:00 - 11:30 am ET
Breakfast will be served
 
 
Where: The Holeman Lounge
National Press Club 
529 14th Street, NW, 13th Floor 
Washington D.C. 20045
 
To RSVP: [email protected]
If you would like to attend, please contact Mario Coluccio to check on availability. Space is limited.
 
Article Photo Credit: by is licensed under
Sign Up for Our Email Newsletter

RECENT NEWS

New JCI Viewpoint: FDA Must Rethink How It Evaluates Precision Medicines for Rare Diseases

New JCI Viewpoint: FDA Must Rethink How It Evaluates Precision Medicines for Rare Diseases

Authors argue that rare disease innovation requires learning more from fewer patients—not enrolling more patients...  Read more

Troubling Trends: Systemic Practices in Texas' Non-Profit Hospitals That Inflate Health Care Costs

Troubling Trends: Systemic Practices in Texas' Non-Profit Hospitals That Inflate Health Care Costs

Texas has an opportunity to lead rather than react. Better measurement would strengthen public confidence without diminis...  Read more

PROTECTING THE U.S. PHARMACEUTICAL SUPPLY CHAIN: A PATH FORWARD

PROTECTING THE U.S. PHARMACEUTICAL SUPPLY CHAIN: A PATH FORWARD

How proactive FDA policies can help strengthen the American pharmaceutical supply chain of essential medicines, create jo...  Read more

DRUGWONKS BLOG